XML 75 R58.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Acquisitions and Other Arrangements - Additional Information (Detail) |  |  | 1 Months Ended | 3 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | ---
Feb. 22, 2018 USD ($) | Jul. 27, 2017 USD ($) | Jan. 31, 2018 USD ($) Product | Dec. 31, 2017 USD ($) | Dec. 31, 2018 USD ($) | Dec. 31, 2017 USD ($) | Dec. 31, 2016 USD ($) | Dec. 31, 2015 USD ($)
Acquisitions And Collaborations [Line Items] |  |  |  |  |  |  |  |
Total cash consideration, net of cash acquired |  |  |  |  |  | $ 686,000,000 | $ 48,000,000 | $ 34,000,000
Integration costs |  |  |  |  |  |  | 26,000,000 | 73,000,000
Development and regulatory milestone payments, maximum |  |  |  | $ 25,000,000 |  | 25,000,000 |  |
Claris Injectables Limited |  |  |  |  |  |  |  |
Acquisitions And Collaborations [Line Items] |  |  |  |  |  |  |  |
Percentage of ownership acquired |  | 100.00% |  |  |  |  |  |
Total cash consideration, net of cash acquired |  | $ 629,000,000 |  |  |  |  |  |
Increase to other intangible assets |  |  |  | 45,000,000 |  |  |  |
Increase to deferred tax and uncertain tax position liabilities |  |  |  | 26,000,000 |  |  |  |
Decrease in goodwill |  |  |  | 19,000,000 |  |  |  |
Amount allocated from total consideration to acquire intangible assets |  | 280,000,000 |  |  |  |  |  |
Claris Injectables Limited | Subsequent Event |  |  |  |  |  |  |  |
Acquisitions And Collaborations [Line Items] |  |  |  |  |  |  |  |
Business acquisition settlement claims received | $ 73,000,000 |  |  |  |  |  |  |
Accrued liabilities released | $ 7,000,000 |  |  |  |  |  |  |
Claris Injectables Limited | Scenario Forecast |  |  |  |  |  |  |  |
Acquisitions And Collaborations [Line Items] |  |  |  |  |  |  |  |
Business acquisition benefit of settlement claims and accrued liabilities released |  |  |  |  | $ (80,000,000) |  |  |
Claris Injectables Limited | IPR&D |  |  |  |  |  |  |  |
Acquisitions And Collaborations [Line Items] |  |  |  |  |  |  |  |
Amount allocated from total consideration to acquire IPR&D with indefinite useful life |  | $ 140,000,000 |  |  |  |  |  |
Discount rate used to measure intangible assets |  | 13.00% |  |  |  |  |  |
Claris Injectables Limited | Developed Technology |  |  |  |  |  |  |  |
Acquisitions And Collaborations [Line Items] |  |  |  |  |  |  |  |
Amount allocated from total consideration to acquire intangible assets |  | $ 140,000,000 |  |  |  |  |  |
Acquired intangible assets, weighted-average useful life |  | 8 years |  |  |  |  |  |
Discount rate used to measure intangible assets |  | 12.00% |  |  |  |  |  |
Claris Injectables Limited | Marketing and Administrative Expenses |  |  |  |  |  |  |  |
Acquisitions And Collaborations [Line Items] |  |  |  |  |  |  |  |
Acquisition costs |  |  |  |  |  | 28,000,000 |  |
Integration costs |  |  |  |  |  | 28,000,000 |  |
Mallinckrodt plc | Subsequent Event | RECOTHROM and PREVELEAK |  |  |  |  |  |  |  |
Acquisitions And Collaborations [Line Items] |  |  |  |  |  |  |  |
Number of products agreed to acquired | Product |  |  | 2 |  |  |  |  |
Purchase price, upfront payment |  |  | $ 153,000,000 |  |  |  |  |
Celerity Pharmaceutical LLC |  |  |  |  |  |  |  |
Acquisitions And Collaborations [Line Items] |  |  |  |  |  |  |  |
Payment to acquire the rights |  |  |  |  |  | $ 20,000,000 | $ 23,000,000 | $ 14,000,000
Estimated economic lives |  |  |  |  |  | 12 years |  |
Maximum potential future payments |  |  |  | $ 243,000,000 |  | $ 243,000,000 |  |

X
- Definition Acquisitions and collaborations. + References No definition available. + Details
Name: | bax_AcquisitionsAndCollaborationsLineItems
Namespace Prefix: | bax_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business acquisition, purchase price upfront payment. + References No definition available. + Details
Name: | bax_BusinessAcquisitionPurchasePriceUpfrontPayment
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business acquisition settlement claims received.. + References No definition available. + Details
Name: | bax_BusinessAcquisitionSettlementClaimsReceived
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business combination accrued liabilities released. + References No definition available. + Details
Name: | bax_BusinessCombinationAccruedLiabilitiesReleased
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business combination benefit of settlement claims and accrued liabilities released. + References No definition available. + Details
Name: | bax_BusinessCombinationBenefitOfSettlementClaimsAndAccruedLiabilitiesReleased
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business combination, provisional information, initial accounting incomplete, adjustment, deferred tax and uncertain tax position liabilities. + References No definition available. + Details
Name: | bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAndUncertainTaxPositionLiabilities
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business combination, provisional information, initial accounting incomplete, adjustment, other intangible assets. + References No definition available. + Details
Name: | bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherIntangibleAssets
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Development and regulatory milestone payments maximum. + References No definition available. + Details
Name: | bax_DevelopmentAndRegulatoryMilestonePaymentsMaximum
Namespace Prefix: | bax_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of products to be acquired. + References No definition available. + Details
Name: | bax_NumberOfProductsToBeAcquired
Namespace Prefix: | bax_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 + Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 23 -URI http://asc.fasb.org/extlink&oid=84229725&loc=d3e1043-128460 + Details
Name: | us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs. + References No definition available. + Details
Name: | us-gaap_BusinessCombinationIntegrationRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of intangible assets, excluding goodwill, acquired at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueInputsDiscountRate
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=84229725&loc=d3e961-128460 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 + Details
Name: | us-gaap_GoodwillPurchaseAccountingAdjustments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bax_ClarisInjectablesLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=bax_InProcessResearchAndDevelopmentAssetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bax_MallinckrodtPlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=bax_RecothromAndPreveleakMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bax_CelerityPharmaceuticalLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |